Case Report: Emergency CABG Following Failure of PTCA in a COVID-19 Patient

Silvia Romiti1, Marco Totaro1, Amalia Laderchi2

  • 1Department of Clinical, Internal Medicine, Anaesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

Insights

This case report details a successful emergency coronary artery bypass grafting (CABG) in a COVID-19 patient. It highlights the management of cardiac surgery during the pandemic when guidelines are lacking.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Cardiovascular Surgery

Background:

  • The COVID-19 pandemic poses risks for patients undergoing cardiac surgery.
  • Cardiopulmonary bypass (CPB) and SARS-CoV-2 infection share mechanisms like cytokine storms and hemostatic issues.
  • Standard protocols for managing pre-operative COVID-19 patients needing urgent cardiac surgery are absent.

Observation:

  • A patient presented with unstable angina and coronary artery dissection requiring urgent intervention.
  • The patient had a confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection.
  • Emergency coronary artery bypass grafting (CABG) was performed using cardiopulmonary bypass (CPB).

Findings:

  • The emergency CABG surgery in the COVID-19 positive patient was successful.
  • This case demonstrates the feasibility of performing complex cardiac surgery in infected patients.
  • Effective management strategies can mitigate risks associated with combined SARS-CoV-2 and CPB.

Implications:

  • This case provides valuable insights into managing non-deferrable cardiac surgeries during the COVID-19 pandemic.
  • It suggests that with careful planning, cardiac surgery can be safely performed in COVID-19 patients.
  • Further research is needed to establish evidence-based guidelines for this patient population.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
288
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
96